Ocular herpes simplex virus type 1: is the cornea a reservoir for viral latency or a fast pit stop?
about
Immunological aspects of acute and recurrent herpes simplex keratitisOcular herpes simplex virus: how are latency, reactivation, recurrent disease and therapy interrelated?Ganciclovir ophthalmic gel 0.15% for the treatment of acute herpetic keratitis: background, effectiveness, tolerability, safety, and future applicationsPathogens penetrating the central nervous system: infection pathways and the cellular and molecular mechanisms of invasionCathelicidin LL-37 and HSV-1 Corneal Infection: Peptide Versus Gene Therapy.Frequency of dendritiform inflammatory cells in the cornea in herpetic anterior uveitis without clinical keratitis and Fuchs uveitisUptake and bioconversion of stereoisomeric dipeptide prodrugs of ganciclovir by nanoparticulate carriers in corneal epithelial cells.HSV-1 miR-H6 inhibits HSV-1 replication and IL-6 expression in human corneal epithelial cells in vitro.Rabbit and mouse models of HSV-1 latency, reactivation, and recurrent eye diseasesReal-time polymerase chain reaction for the diagnosis of necrotizing herpes stromal keratitis.Novel biotinylated lipid prodrugs of acyclovir for the treatment of herpetic keratitis (HK): transporter recognition, tissue stability and antiviral activityInterrelationship of Primary Virus Replication, Level of Latency, and Time to Reactivation in the Trigeminal Ganglia of Latently Infected Mice.Nanoparticle-based topical ophthalmic formulation for sustained release of stereoisomeric dipeptide prodrugs of ganciclovir.Virological and molecular biological evidence supporting herpes simplex virus type 1 corneal latency.Targeting herpetic keratitis by gene therapy.Glial fibrillary acidic protein expression during HSV-1 infection in mouse cornea.
P2860
Q27016103-B31BCF49-6DF1-4282-870D-E90CD1C8C49EQ27021069-D3CA503B-888E-4F3F-AE0A-E3B6BD9B701EQ27026675-B251411E-A7FB-4A47-ACA6-C3044403A5F0Q27027234-7C65D2F8-6A01-436F-A21D-FAA00FC3199BQ33704754-D269E633-4985-491A-965B-FFE1C7EA92D0Q35388501-83544A25-D0A7-424A-B3DF-2C15A18CB3D7Q35578510-E2E4A6A1-1C12-49C2-A7A7-0192E0317F4BQ35896981-FB1540D3-8501-4C7B-B903-5B057D258BB7Q36307684-E38BB8EB-B26C-40CF-A66F-D6995E4B5073Q36951148-8C9E72D8-E2BF-4FA7-A21D-BBDFEE80DC33Q37103787-2DDA11BF-9AE0-49A9-806D-0893F4185800Q37300339-8777A77F-7F93-4F1F-BF50-BC44440DFB43Q40540577-6DAA6D74-3215-4252-AAAD-8B54A0273951Q41542418-CB8752F3-DD17-4633-B3F1-73AF70DA1123Q41951959-C35EAAEF-A901-4ECF-ACA6-F7B982E2A67EQ50915756-042B8AC7-5D4B-4C22-B2E7-1F8F74BFF048
P2860
Ocular herpes simplex virus type 1: is the cornea a reservoir for viral latency or a fast pit stop?
description
2011 nî lūn-bûn
@nan
2011 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մարտին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Ocular herpes simplex virus ty ...... al latency or a fast pit stop?
@ast
Ocular herpes simplex virus ty ...... al latency or a fast pit stop?
@en
Ocular herpes simplex virus ty ...... al latency or a fast pit stop?
@nl
type
label
Ocular herpes simplex virus ty ...... al latency or a fast pit stop?
@ast
Ocular herpes simplex virus ty ...... al latency or a fast pit stop?
@en
Ocular herpes simplex virus ty ...... al latency or a fast pit stop?
@nl
prefLabel
Ocular herpes simplex virus ty ...... al latency or a fast pit stop?
@ast
Ocular herpes simplex virus ty ...... al latency or a fast pit stop?
@en
Ocular herpes simplex virus ty ...... al latency or a fast pit stop?
@nl
P2093
P2860
P1433
P1476
Ocular herpes simplex virus ty ...... al latency or a fast pit stop?
@en
P2093
Christian Clement
David P Kennedy
James M Hill
Partha S Bhattacharjee
Richard L Arceneaux
Tashfin S Huq
P2860
P304
P356
10.1097/ICO.0B013E3181EF241D
P577
2011-03-01T00:00:00Z